Ohio-based Minimally Invasive Devices capped an $11.5 million Series B funding round with a final $2.5 million investment from Radius Ventures, according to a company statement.
MID said it’s putting the new cash into marketing and sales for its FDA-cleared device for laparoscopic surgeons, the FloShield vision system.
Sign up to get our free newsletters delivered right to your inbox.
[sead]